archive image

European Commission - Research - Biosociety

Biosociety and the Knowledge-Based Bio-Economy
Knowledge based bio-economy
EU-funded research











News & Events
Page last update: 25/12/2008

India to increase biotech research ties with EU

India is known for its large pool of talented scientists, world-class IT industry and successful pharmaceutical sector. All these factors have enabled the country to become an emerging player in the global biotechnology arena. India also has an advantage over other countries: with a population of over a billion people there is a huge market for products and services. The country also has an enormous number of plant and animal species, which can be utilised by biotech companies.

The EU recognises India’s growing importance in the field of biotechnology and the two are set to deepen their biotechnology research ties, particularly in the fields of food and health. A delegation from the EU recently visited India to discuss cooperation over issues such as the links between health and nutrition and how these can be exploited to help prevent chronic diseases.

'We went there with a group of leading EU scientists and we wanted to try to establish contacts with the food research community, which we didn't know very well,' explained Dr Antonio di Giulio, Head of the Food, Health and Well-Being Unit at the European Commission's Research Directorate-General.

A growing market

One of the highlights of the trip was a joint EU-India day at a major summit on nutraceuticals. Nutraceuticals (the word comes from combining 'nutrition' and 'pharmaceuticals') are dietary supplements made from food extracts, which are designed to have health benefits. They include antioxidants from berries, and oils from certain fish.

The world market in nutraceuticals is worth over US $80 billion. The US and Japan currently have the largest market share, but interest in these products is growing rapidly in both the EU and India. Both the EU and India are also interested in promoting research designed to find out more about these products and how they work.

However, while nutraceuticals dominated the discussions, other topics also featured in the talks. 'We discussed aspects linked to personalised nutrition, we discussed aspects linked to how to prevent certain neurodegenerative diseases, like for instance Alzheimer's, with specific diets,' Dr di Giulio told CORDIS News. 'We also discussed more about how our gut flora will be enhanced with some food products.'

Dr di Giulio described the trip as 'very fruitful'. 'I must say that I was very much impressed by the capabilities they have, by their way of thinking ahead and the way of collaborating that is really on an equal footing,' he commented.

Mutual benefits

The feeling is clearly shared; on a trip to Brussels to firm up cooperation in the food and nutraceuticals fields, Dr S Natesh, Head of International Cooperation at the Department of Biotechnology of the Government of India, told CORDIS News why India is so keen to work with the EU.

'The EU is a very important region for us. We have a lot of respect for the kind of research and innovation in the EU region, and more importantly we perceive that there are complementary strengths between the EU and India,' he stated.

'We are very strong on manufacturing capabilities and services, and now we're slowly moving into discovery and innovation. And the EU has traditionally been a region where a lot of innovation has taken place. So we feel that by marrying our strengths, we could help bring in more synergy into this entire enterprise and look for new products, processes, publicise good research and so on.'

Source: CORDIS News

For further information:
FP7 funding for research on food, agriculture, fisheries and biotechnology ,
Nutraceuticals summit

Last update: 25 December 2008 | Top